Question 1

What does Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy do?

Accepted Answer

EU Funded (H2020) Research Project

Question 2

How can I contact Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy?

Accepted Answer

You can contact Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy directly through their booth page at https://liveexpofloor.com/b/investigating-the-recognition-of-a-novel. Use the contact form to send a message — no account required.

Question 3

Is Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy at a virtual expo?

Accepted Answer

Yes — Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy has a virtual booth on LiveExpoFloor, in the FinTech & Payments category. Visit their booth 24/7, watch demos, and connect with the team live.

Question 4

What is the website of Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy?

Accepted Answer

The official website of Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy is http://www.tumor-immunology-utrecht.nl/news/2017/3/9/eu-grant-for-dennis-beringer-group-kuball.

Investigating the recognition of a novel ligand by gamma-delta T cells and the translation of this interaction into molecules for future cancer immunotherapy

About